Premium
Transcatheter aortic valve thrombosis: The more we see the more we know
Author(s) -
Franzone Anna,
Esposito Giovanni
Publication year - 2021
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/ccd.29845
Subject(s) - medicine , thrombosis , complication , balloon , aortic valve , prosthesis , surgery , cardiology , anticoagulant therapy , radiology
Key Points Valve thrombosis is a rare but relevant and potentially fatal complication of transcatheter interventions (TAVI) that is usually resolved by oral anticoagulant therapy. Advanced imaging including 4D‐CT is pivotal for the diagnosis. Patient‐ and procedure‐related factors that increase the risk of valve thrombosis include obesity, renal failure, thrombocytopenia, valve‐in‐valve implantation, lack of predilation, and use of balloon‐expandable prosthesis.